Schrödinger, Inc. develops a physics-based computational platform for drug discovery and materials science. Its software predicts molecular properties to accelerate therapeutic and materials development. The platform is licensed to biopharmaceutical companies, academic institutions, and government labs globally. Schrödinger also runs collaborative and proprietary drug discovery programs, with clinical-stage assets including SGR-1505 (MALT1 inhibitor) and SGR-3515 (Wee1/Myt1 inhibitor), generating $255.9 million in total revenue in 2025.
expected 2027-02-03
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001490978-26-000010 | EDGAR | 130K words |
| 2025-02-26 | 2024-12-31 | 0001490978-25-000014 | EDGAR | 127K words |
| 2024-02-28 | 2023-12-31 | 0001490978-24-000018 | EDGAR | 117K words |
| 2023-02-28 | 2022-12-31 | 0001490978-23-000024 | EDGAR | 114K words |
| 2022-02-24 | 2021-12-31 | 0001564590-22-006713 | EDGAR | 108K words |
| 2021-03-04 | 2020-12-31 | 0001564590-21-010727 | EDGAR | 98K words |
| 2020-03-16 | 2019-12-31 | 0001564590-20-011182 | EDGAR | 115K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-04 | 2026-09-30 | 0001490978-26-000076 | EDGAR | 77K words |
| 2026-08-05 | 2026-06-30 | 0001490978-26-000068 | EDGAR | 77K words |
| 2025-11-05 | 2025-09-30 | 0001490978-25-000117 | EDGAR | 76K words |
| 2025-08-06 | 2025-06-30 | 0001490978-25-000100 | EDGAR | 74K words |
| 2025-05-07 | 2025-03-31 | 0001490978-25-000059 | EDGAR | 70K words |
| 2024-11-12 | 2024-09-30 | 0001490978-24-000089 | EDGAR | 67K words |
| 2024-07-31 | 2024-06-30 | 0001490978-24-000072 | EDGAR | 66K words |
| 2024-05-01 | 2024-03-31 | 0001490978-24-000046 | EDGAR | 62K words |
| 2023-11-01 | 2023-09-30 | 0001490978-23-000109 | EDGAR | 66K words |
| 2023-08-02 | 2023-06-30 | 0001490978-23-000090 | EDGAR | 66K words |
| 2023-05-04 | 2023-03-31 | 0001490978-23-000048 | EDGAR | 62K words |
| 2022-11-03 | 2022-09-30 | 0001490978-22-000012 | EDGAR | 60K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-04 | 0001490978-26-000075 | EDGAR | 5K words |
| 2026-08-05 | 0001490978-26-000067 | EDGAR | 5K words |
| 2026-03-12 | 0001490978-26-000013 | EDGAR | 1K words |
| 2026-02-25 | 0001490978-26-000009 | EDGAR | 6K words |
| 2025-11-05 | 0001490978-25-000116 | EDGAR | 5K words |
| 2025-09-08 | 0001490978-25-000106 | EDGAR | 5K words |
| 2025-08-06 | 0001490978-25-000099 | EDGAR | 5K words |
| 2025-06-18 | 0001490978-25-000082 | EDGAR | 1K words |
| 2025-05-20 | 0001193125-25-122800 | EDGAR | 12K words |
| 2025-05-19 | 0001193125-25-122461 | EDGAR | 1K words |
89 total filings indexed. 60 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001490978 |
| Ticker | SDGR |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.schrodinger.com |
| Listed | 2020-02-06 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/SDGR (~200 tokens, structured JSON with cryptographic provenance)